Catalyst Crew Technologies Corp. (OTC: CCTC) has announced its corporate mission statement and strategic objectives for 2026 as the company continues its transition toward artificial intelligence-enabled healthcare technology solutions focused on emerging markets. The company clarified that a previous press release included an incorrect link to its Current Report on Form 8-K, with the correct filing available at https://www.sec.gov/Archives/edgar/data/1477960/000147793226001029/cctc_8k.htm. The company's mission is to develop scalable, artificial intelligence-driven healthcare technologies that improve access, efficiency, and care coordination across emerging markets. By combining digital health infrastructure, data intelligence, and strategic partnerships, Catalyst Crew aims to support more connected and effective healthcare delivery systems, with an initial focus on Latin America.
For 2026, the company has identified several strategic priorities designed to support the continued development of its AI-enabled healthcare platform. Key objectives include advancing the core artificial intelligence-driven healthcare technology framework, expanding digital health infrastructure initiatives in telehealth services and remote patient monitoring, and establishing strategic healthcare and technology partnerships. Additional priorities involve evaluating targeted technology acquisitions that may accelerate development of the company's AI healthcare platform and digital infrastructure, strengthening operational and corporate infrastructure to support long-term growth as a public company, and expanding market engagement efforts across Latin America where digital healthcare infrastructure and AI-driven technologies may support improved healthcare access and system efficiency.
Dr. Kevin Rodan Levy, Chief Executive Officer of Catalyst Crew Technologies Corp., stated that the mission reflects a disciplined commitment to developing scalable digital healthcare technologies designed to address real operational challenges in healthcare delivery. Throughout 2026, the company is focused on advancing the foundational technologies, partnerships, and operational infrastructure that will support the long-term development of its platform. The company emphasized that it is a development-stage enterprise that has not generated revenues from its newly announced business direction. The announcement relates solely to a change in corporate strategy and proposed corporate actions and does not represent the completion of commercial deployment or revenue-generating operations. The company's securities involve a high degree of risk, and prospective investors are urged to carefully review all risk factors and disclosures contained in the company's SEC filings before making any investment decision.
